NO930244L - Umettede 17beta-substituerte 3-karboksysteroider - Google Patents

Umettede 17beta-substituerte 3-karboksysteroider

Info

Publication number
NO930244L
NO930244L NO93930244A NO930244A NO930244L NO 930244 L NO930244 L NO 930244L NO 93930244 A NO93930244 A NO 93930244A NO 930244 A NO930244 A NO 930244A NO 930244 L NO930244 L NO 930244L
Authority
NO
Norway
Prior art keywords
group
hydrogen
cycloalkyl
alkyl group
alkyl
Prior art date
Application number
NO93930244A
Other languages
English (en)
Other versions
NO930244D0 (no
Inventor
Achille Panzeri
Marcella Nesi
Enrico Di Salle
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of NO930244D0 publication Critical patent/NO930244D0/no
Publication of NO930244L publication Critical patent/NO930244L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28Antiandrogens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Details Of Garments (AREA)
  • Ceramic Products (AREA)
  • Dental Preparations (AREA)

Abstract

Foreliggende oppfinnelse vedrører steroide 5a-reduktase-inhibitorer med følgende formel: (I) hvor Y er oksygen eller svovel; R er en gruppe a) -OR4, hvor R4 er hydrogen eller C^-C6 alkylgruppe; b) -NR5R6, hvor hver av R5 og R6 , uavhengig, er hydrogen eller en C^-Cg alkylgruppe; c) -O-CHR7-W, hvor R7 er hydrogen eller en C-±-C6 alkyl- gruppe, og W er en gruppe (i) -O-CO-R, hvor R er en g 8 alkylgruppe, og C5- C6 cykloalkylgruppe, en C6-C9 cykloalkylalkyl- gruppe, en fenylgruppe eller en benzylgruppe; (ii) -O-CO-O-Rg, hvor Rg er en alkylgruppe eller en C5-C6 cykloalkylgruppe; eller (iii) -CO-NR5Rg, hvor R$ og R6 er som definert ovenfor; d) -0-(CH2)n-NR10Rllr hvor hver av R10 og R^i er, uav- hengig, hydrogen eller en C^-Cg alkylgruppe eller sammen med nitrogenatomet som de er bundet til, danner en pent- atomisk eller heksatomisk mettet heteromoncyklisk ring, som eventuelt inneholder minst ett ytterligere hetero- atom valgt fra oksygen og nitrogen, og n er et helt tall på 2 - 4 ; R^ er hydrogen, en c^-Cg alkylgruppe, en C5~C6 cyklo- alkyl-gruppe, en Cg-Cg cykloalkylgruppe eller en aryl- gruppe ; hver av R2 og R3 er uavhengig valgt valgt fra gruppen som består av hydrogen, C^-C6 alkyl, C5-C6 cykloalkyl, C6-Cg cykloalkylalkyl og aryl eller R2 og R3, sammen med nitrogenatomet som de er bundet til, danner en pentatom- isk eller heksatomisk mettet heteromonocyklisk ring, eventuelt inne-holdende minst et ytterligere heteroatom valgt fra oksygen og nitrogen; og symbolet t----1 repre- senterer en enkel- eller en dobbelbinding forutsatt at når det er en dobbel-binding, eksisterer ikke hydrogen i 5a-stilling. Med hensyn til deres 5a-reduktase-inhibitoriske aktivi- tet kan forbindelsene av oppfinnelsen bli nyttig i behandlingen av androgenavhengige tilstander.
NO93930244A 1991-05-24 1993-01-25 Umettede 17beta-substituerte 3-karboksysteroider NO930244L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI911432A IT1259419B (it) 1991-05-24 1991-05-24 Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
PCT/EP1992/001153 WO1992020700A1 (en) 1991-05-24 1992-05-22 UNSATURATED 17β-SUBSTITUTED 3-CARBOXY STEROIDS

Publications (2)

Publication Number Publication Date
NO930244D0 NO930244D0 (no) 1993-01-25
NO930244L true NO930244L (no) 1993-01-27

Family

ID=11359980

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930244A NO930244L (no) 1991-05-24 1993-01-25 Umettede 17beta-substituerte 3-karboksysteroider

Country Status (26)

Country Link
US (1) US5212166A (no)
EP (2) EP0540717B1 (no)
JP (1) JP3226919B2 (no)
CN (1) CN1035055C (no)
AT (1) ATE155792T1 (no)
AU (1) AU655280B2 (no)
CA (1) CA2087953A1 (no)
CZ (1) CZ281309B6 (no)
DE (1) DE69221074T2 (no)
DK (1) DK0540717T3 (no)
ES (1) ES2106185T3 (no)
FI (1) FI930277A0 (no)
HU (1) HUT64083A (no)
ID (1) ID954B (no)
IE (1) IE921634A1 (no)
IL (1) IL101947A (no)
IT (1) IT1259419B (no)
MX (1) MX9202438A (no)
MY (1) MY131089A (no)
NO (1) NO930244L (no)
NZ (1) NZ242850A (no)
RU (1) RU2104283C1 (no)
TW (1) TW213467B (no)
WO (1) WO1992020700A1 (no)
YU (1) YU52992A (no)
ZA (1) ZA923758B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI945105A0 (fi) * 1992-04-30 1994-10-31 Smithkline Beecham Corp 17alfa- ja 17beta-substituoitu estra-1,3,5(10)-trieeni-3-karboksyylihappo
US5683995A (en) * 1992-11-18 1997-11-04 Smithkline Beecham Corporation 17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors
US5641765A (en) * 1992-11-18 1997-06-24 Smithkline Beecham Corporation 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
ES2185666T3 (es) * 1993-09-03 2003-05-01 Smithkline Beecham Corp Formulacion estabilizada para comprimidos.
GB9324371D0 (en) * 1993-11-26 1994-01-12 Erba Carlo Spa Side chain fluoro substituted 3-carboxysteroids
US5430157A (en) * 1993-12-13 1995-07-04 Eli Lilly And Company Reduced phenanthrenes
GB9402041D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Corp Compounds
US5714480A (en) * 1994-03-31 1998-02-03 Smithkline Beecham Corporation Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors
WO1995028413A1 (en) * 1994-04-15 1995-10-26 Smithkline Beecham Corporation 17β-SUBSTITUTED 3-CARBOXY STEROIDS THAT INHIBIT 5-α-REDUCTASE
GB9415183D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 3-carboxysteroids with a fluorinated side-chain
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
YU19302A (sh) * 1999-09-22 2004-11-25 Aventis Pharma Deutschland Gmbh. 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US5041433A (en) * 1987-04-29 1991-08-20 Smithkline Beecham Corporation 11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod 5-α-reductase
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US5032586A (en) * 1989-08-24 1991-07-16 Smithkline Beecham Corporation 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase
US5091380A (en) * 1990-06-28 1992-02-25 Merck & Co., Inc. N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors
EP0725074A3 (en) * 1992-04-20 1996-11-20 Sankyo Co Intermediate compounds for the preparation of androst-3,5-diene-3-carboxy derivatives

Also Published As

Publication number Publication date
IL101947A (en) 1996-01-19
MY131089A (en) 2007-07-31
ES2106185T3 (es) 1997-11-01
US5212166A (en) 1993-05-18
ID954B (id) 1996-09-25
HUT64083A (en) 1993-11-29
JP3226919B2 (ja) 2001-11-12
DE69221074T2 (de) 1997-11-13
CZ281309B6 (cs) 1996-08-14
CZ26593A3 (en) 1993-11-17
EP0540717A1 (en) 1993-05-12
IT1259419B (it) 1996-03-18
HU9300176D0 (en) 1993-04-28
MX9202438A (es) 1992-11-01
AU1778192A (en) 1992-12-30
NZ242850A (en) 1994-01-26
CA2087953A1 (en) 1992-11-25
CN1035055C (zh) 1997-06-04
AU655280B2 (en) 1994-12-15
ATE155792T1 (de) 1997-08-15
JPH06500342A (ja) 1994-01-13
FI930277A7 (fi) 1993-01-22
ITMI911432A1 (it) 1992-11-24
ZA923758B (en) 1993-01-27
IE921634A1 (en) 1992-12-02
RU2104283C1 (ru) 1998-02-10
NO930244D0 (no) 1993-01-25
TW213467B (no) 1993-09-21
EP0540717B1 (en) 1997-07-23
ITMI911432A0 (it) 1991-05-24
WO1992020700A1 (en) 1992-11-26
EP0517047A1 (en) 1992-12-09
DE69221074D1 (de) 1997-09-04
DK0540717T3 (da) 1997-08-18
FI930277A0 (fi) 1993-01-22
CN1067057A (zh) 1992-12-16
YU52992A (sh) 1995-03-27

Similar Documents

Publication Publication Date Title
NO913923L (no) 17beta-substituerte-4-aza-5alfa-androstan-3-on-derivater ogfremgangsmaate ved fremstilling av disse
NO20091012L (no) Kinazolinon- og isokinolinonacetamid derivater
DK0623140T3 (da) Nye 19-nor steroider med en svovlcarbonkæde i 11-beta stilling, fremgangsmåde til deres fremstilling og mellemstofferne der
DK117986D0 (da) Arylderivater, fremgangsmaader til deres fremstilling og deres anvendelse
NO20071873L (no) DNA-PK inhibotorer.
NO20065573L (no) Orto-substituerte aryl eller heteroarylamidforbindelser
YU46497B (sh) Postupak za dobijanje novih derivata pirazola
RU2005108046A (ru) 1, 2, 3-триазольные производные, обладающие бактерицидной (например, фунгицидной)активностью
DE69221074D1 (de) Ungesatigte 17-beta-substituierte-3-carboxy steroide
TW200503704A (en) N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
NO20073787L (no) Nye pyrimidin-nukleosidforbindelser eller dets salt
NO951283L (no) Nye taxanderivater, deres fremstilling samt farmasöytiske preparater inneholdende derivatene
NO944926L (no) Fremgangsmåter for å inhibere myeloperoksidaseaktivitet
NO972951L (no) Stabilisatorer for pulverlakker
FI914504A0 (fi) Substituerade 4-amino-3-pyridinoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
DE69200284D1 (de) Verwendung von 4-(3-trifluormethylphenyl)-1,2,3,6-Tetrahydropyridinderivaten als freie Radikalfänger.
ES2027357T3 (es) Una composicion herbicida y su procedimiento de preparacion.
ES468408A1 (es) Procedimiento para la preparacion de 1,2,3-tiadiazol-3-in-5-iliden-ureas.
NO951433L (no) Kjemiske forbindelser
NO20054053L (no) Triazolforbindelser anvendbare i terapi.
ES483214A1 (es) Un procedimiento para la preparacion de compuestos derivadosde morfolina y piperidina
NO951072L (no) Polyjoderte forbindelser, fremgangsmåte for deres fremstilling og diagnostisk preparat
GB1336263A (en) 9-substituted erythromycin a and b oximes
ATE316953T1 (de) Stabilisator für hydroxylaminlösungen
TR199900768T2 (xx) Hidroksimik ve hidrazonik gruplu fungisidler.